Lycera Appoints Bruce Goldsmith, Ph.D., as Chief Business Officer
Lycera Corp., a biopharmaceutical company pioneering the development of breakthrough oral medicines to treat autoimmune diseases, today announced the appointment of Bruce A. Goldsmith, Ph.D., as chief business officer.
No comments:
Post a Comment